These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 34649182)

  • 1. Discovery of PT-65 as a highly potent and selective Proteolysis-targeting chimera degrader of GSK3 for treating Alzheimer's disease.
    Qu L; Li S; Ji L; Luo S; Ding M; Yin F; Wang C; Luo H; Lu D; Liu X; Peng W; Kong L; Wang X
    Eur J Med Chem; 2021 Dec; 226():113889. PubMed ID: 34649182
    [TBL] [Abstract][Full Text] [Related]  

  • 2. GSK3: A potential target and pending issues for treatment of Alzheimer's disease.
    Zhao J; Wei M; Guo M; Wang M; Niu H; Xu T; Zhou Y
    CNS Neurosci Ther; 2024 Jul; 30(7):e14818. PubMed ID: 38946682
    [TBL] [Abstract][Full Text] [Related]  

  • 3. FLZ alleviates the memory deficits in transgenic mouse model of Alzheimer's disease via decreasing beta-amyloid production and tau hyperphosphorylation.
    Bao XQ; Li N; Wang T; Kong XC; Tai WJ; Sun H; Zhang D
    PLoS One; 2013; 8(11):e78033. PubMed ID: 24223757
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Glycogen Synthase Kinase 3 (GSK3): Its Role and Inhibitors.
    Wadhwa P; Jain P; Jadhav HR
    Curr Top Med Chem; 2020; 20(17):1522-1534. PubMed ID: 32416693
    [TBL] [Abstract][Full Text] [Related]  

  • 5. C-Glycosylflavones Alleviate Tau Phosphorylation and Amyloid Neurotoxicity through GSK3β Inhibition.
    Liang Z; Zhang B; Su WW; Williams PG; Li QX
    ACS Chem Neurosci; 2016 Jul; 7(7):912-23. PubMed ID: 27213824
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Design, synthesis and biological evaluation of harmine derivatives as potent GSK-3β/DYRK1A dual inhibitors for the treatment of Alzheimer's disease.
    Liu W; Liu X; Tian L; Gao Y; Liu W; Chen H; Jiang X; Xu Z; Ding H; Zhao Q
    Eur J Med Chem; 2021 Oct; 222():113554. PubMed ID: 34098466
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Discovery of highly potent human glutaminyl cyclase (QC) inhibitors as anti-Alzheimer's agents by the combination of pharmacophore-based and structure-based design.
    Van Manh N; Hoang VH; Ngo VTH; Ann J; Jang TH; Ha JH; Song JY; Ha HJ; Kim H; Kim YH; Lee J; Lee J
    Eur J Med Chem; 2021 Dec; 226():113819. PubMed ID: 34536669
    [TBL] [Abstract][Full Text] [Related]  

  • 8. SLOH, a carbazole-based fluorophore, mitigates neuropathology and behavioral impairment in the triple-transgenic mouse model of Alzheimer's disease.
    Wu X; Kosaraju J; Zhou W; Tam KY
    Neuropharmacology; 2018 Mar; 131():351-363. PubMed ID: 29309769
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Blockade of Tau hyperphosphorylation and Aβ₁₋₄₂ generation by the aminotetrahydrofuran derivative ANAVEX2-73, a mixed muscarinic and σ₁ receptor agonist, in a nontransgenic mouse model of Alzheimer's disease.
    Lahmy V; Meunier J; Malmström S; Naert G; Givalois L; Kim SH; Villard V; Vamvakides A; Maurice T
    Neuropsychopharmacology; 2013 Aug; 38(9):1706-23. PubMed ID: 23493042
    [TBL] [Abstract][Full Text] [Related]  

  • 10. GSK3: a key target for the development of novel treatments for type 2 diabetes mellitus and Alzheimer disease.
    Gao C; Hölscher C; Liu Y; Li L
    Rev Neurosci; 2011 Dec; 23(1):1-11. PubMed ID: 22718609
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The selective GSK3 inhibitor, SAR502250, displays neuroprotective activity and attenuates behavioral impairments in models of neuropsychiatric symptoms of Alzheimer's disease in rodents.
    Griebel G; Stemmelin J; Lopez-Grancha M; Boulay D; Boquet G; Slowinski F; Pichat P; Beeské S; Tanaka S; Mori A; Fujimura M; Eguchi J
    Sci Rep; 2019 Dec; 9(1):18045. PubMed ID: 31792284
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Design, synthesis and biological evaluation of LX2343 derivatives as neuroprotective agents for the treatment of Alzheimer's disease.
    Sun G; Wang J; Guo X; Lei M; Zhang Y; Wang X; Shen X; Hu L
    Eur J Med Chem; 2018 Feb; 145():622-633. PubMed ID: 29339255
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The novel histone de acetylase 6 inhibitor, MPT0G211, ameliorates tau phosphorylation and cognitive deficits in an Alzheimer's disease model.
    Fan SJ; Huang FI; Liou JP; Yang CR
    Cell Death Dis; 2018 May; 9(6):655. PubMed ID: 29844403
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Discovery of novel series of 2-substituted benzo[d]oxazol-5-amine derivatives as multi-target directed ligands for the treatment of Alzheimer's disease.
    Gutti G; Kakarla R; Kumar D; Beohar M; Ganeshpurkar A; Kumar A; Krishnamurthy S; Singh SK
    Eur J Med Chem; 2019 Nov; 182():111613. PubMed ID: 31437780
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Conundrum of GSK3 Inhibitors: Is it the Dawn of a New Beginning?
    Bhat RV; Andersson U; Andersson S; Knerr L; Bauer U; Sundgren-Andersson AK
    J Alzheimers Dis; 2018; 64(s1):S547-S554. PubMed ID: 29758944
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of GSK3β-mediated BACE1 expression reduces Alzheimer-associated phenotypes.
    Ly PT; Wu Y; Zou H; Wang R; Zhou W; Kinoshita A; Zhang M; Yang Y; Cai F; Woodgett J; Song W
    J Clin Invest; 2013 Jan; 123(1):224-35. PubMed ID: 23202730
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 17beta-estradiol attenuates glycogen synthase kinase-3beta activation and tau hyperphosphorylation in Akt-independent manner.
    Shi HR; Zhu LQ; Wang SH; Liu XA; Tian Q; Zhang Q; Wang Q; Wang JZ
    J Neural Transm (Vienna); 2008 Jun; 115(6):879-88. PubMed ID: 18217188
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synthesis and biological evaluation of selective histone deacetylase 6 inhibitors as multifunctional agents against Alzheimer's disease.
    Wang XX; Xie F; Jia CC; Yan N; Zeng YL; Wu JD; Liu ZP
    Eur J Med Chem; 2021 Dec; 225():113821. PubMed ID: 34517222
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Glycogen synthase kinase 3: a drug target for CNS therapies.
    Bhat RV; Budd Haeberlein SL; Avila J
    J Neurochem; 2004 Jun; 89(6):1313-7. PubMed ID: 15189333
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Piper sarmentosum Roxb. confers neuroprotection on beta-amyloid (Aβ)-induced microglia-mediated neuroinflammation and attenuates tau hyperphosphorylation in SH-SY5Y cells.
    Yeo ETY; Wong KWL; See ML; Wong KY; Gan SY; Chan EWL
    J Ethnopharmacol; 2018 May; 217():187-194. PubMed ID: 29462698
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.